NCT06728462View on ClinicalTrials.gov

A Study of Amorphous Calcium Carbonate in Postmenopausal Women

NARecruitingINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

March 4, 2025

Primary Completion Date

December 14, 2025

Study Completion Date

March 1, 2027

Conditions
CalciumOsteoporosisBone Mineral DensityBone Turnover MarkerDenosumab
Interventions
DIETARY_SUPPLEMENT

Amorphous calcium carbonate

The usual dose for oral use is 5 ACC tablets (equal to 1000 mg calcium element) daily given after meals.

Trial Locations (1)

Unknown

RECRUITING

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors
collaborator

Chang Gung Memorial Hospital

OTHER

lead

Universal Integrated Corp.

INDUSTRY